Company / Shares Outstanding
Arcadia Biosciences, Inc. Shares Outstanding History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
1.4M
FY2025
5-year range
554.6K / 13.5M
FY2021-FY2025
Trend
+6.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding has increased for 3 consecutive years, from 554609.00 in FY2022 to 1364940.00 in FY2025.
Based on SEC 10-K filings.
1364940.00 in FY2025 with a 5-year CAGR of -30.9%.
Increased from 616079.00 to 1364940.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +35.0%
- 5-Year CAGR
- -30.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- Arcadia Biosciences, Inc.'s shares outstanding has grown for 3 consecutive years.
- In FY2025, shares outstanding increased 6.2% year-over-year.
- Peak shares outstanding was recorded in FY2016.
- Lowest shares outstanding in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 1.4M | +6.2% |
| FY2024 | 1.3M | +108.6% |
| FY2023 | 616.1K | +11.1% |
| FY2022 | 554.6K | -95.9% |
| FY2021 | 13.5M | +55.6% |
| FY2020 | 8.6M | +81.1% |
| FY2019 | 4.8M | +123.7% |
| FY2018 | 2.1M | -4.1% |
| FY2017 | 2.2M | -95.0% |
| FY2016 | 44.2M | +2030.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026